Dopamine urges to smoke and the relative salience of drug versus non-drug reward

Social Cognitive and Affective Neuroscience

Volumn 10, Issue 1, 2015, Pages 85-92

  Freeman, Tom P ^a   Das, Ravi K ^a   Kamboj, Sunjeev K ^a   Valerie Curran, H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Attentional bias; Craving; Dopamine; Incentive salience; Reward

Indexed keywords

BENZOTHIAZOLE DERIVATIVE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; PRAMIPEXOLE;

ADOLESCENT; ADULT; AFFECT; ASSOCIATION; ATTENTION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; HUMAN; MALE; MOTIVATION; PHOTOSTIMULATION; PHYSIOLOGY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; REWARD; SMOKING; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; AFFECT; ATTENTION; BENZOTHIAZOLES; CRAVING; CROSS-OVER STUDIES; CUES; DOPAMINE; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MOTIVATION; PHOTIC STIMULATION; REWARD; SMOKING; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84973434239     PISSN: 17495016     EISSN: 17495024     Source Type: Journal    
DOI: 10.1093/scan/nsu026     Document Type: Article

References (61)

1. Aarts, E., van Holstein, M., Cools, R. (2011). Striatal dopamine and the interface between motivation and cognition. Frontiers in Psychology, 2, 163.
2. Anselme, P. (2009). The effect of exposure to drugs on the processing of natural rewards. Neuroscience & Biobehavioral Reviews, 33(3), 314-35.
3. Ataya, A.F., Adams, S., Mullings, E., Cooper, R.M., Attwood, A.S., Munafò , M.R. (2011). Internal reliability of measures of substance-related cognitive bias. Drug and Alcohol Dependence, 121, 148-51.
4. Berridge, K.C. (2012). From prediction error to incentive salience: mesolimbic computation of reward motivation. European Journal of Neuroscience, 35(7), 1124-43.
5. Black, K.J., Hershey, T., Koller, J.M., et al. (2002). A possible substrate for dopaminerelated changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proceedings of the National Academy of Sciences USA, 99(26), 17113-8.
6. Bradley, B.P., Garner, M., Hudson, L., Mogg, K. (2007). Influence of negative affect on selective attention to smoking-related cues and urge to smoke in cigarette smokers. Behavioural Pharmacology, 18(4), 255-63.
7. Bühler, M., Vollstadt-Klein, S., Kobiella, A., et al. (2010). Nicotine dependence is characterized by disordered reward processing in a network driving motivation. Biological Psychiatry, 67(8), 745-52.
8. Caskey, N.H., Jarvik, M.E., Wirshing, W.C. (1999). The effects of dopaminergic D2 stimulation and blockade on smoking behavior. Experimental and Clinical Psychopharmacology, 7(1), 72-8.
9. Caskey, N.H., Jarvik, M.E., Wirshing, W.C., et al. (2002). Modulating tobacco smoking rates by dopaminergic stimulation and blockade. Nicotine & Tobacco Research, 4(3), 259-66.
10. Cools, R., D'Esposito, M. (2011). Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biological Psychiatry, 69(12), 113-25.
11. Cousins, M.S., Stamat, H.M., de Wit, H. (2001). Acute doses of d-amphetamine and bupropion increase cigarette smoking. Psychopharmacology, 157(3), 243-53.
12. Curran, H.V., Drummond, C. (2005). Psychological treatments of substance misuse and dependence. Foresight Brain Science, Addiction and Drugs Project. www.Foresight.gov.uk.
13. Ersche, K.D., Bullmore, E.T., Craig, K.J., et al. (2010). Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence. Archives of General Psychiatry, 67(6), 632.
14. Ferguson, S.G., Shiffman, S., Bruno, R. (2011). Commentary on Fidler et al.(2011): identifying quitters who are at increased risk of relapse-where to from here? Addiction, 106(3), 639-40.
15. Fidler, J.A., Shahab, L., West, R. (2011). Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström test for nicotine dependence and its components. Addiction, 106(3), 631-8.
16. Field, M., Christiansen, P. (2012). Commentary on, 'Internal reliability of measures of substance-related cognitive bias'. Drug and Alcohol Dependence, 124(3), 189-90.
17. Field, M., Cox, W.M. (2008). Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug and Alcohol Dependence, 97(1), 1-20.
18. Field, M., Mogg, K., Bradley, B.P. (2004). Eye movements to smoking-related cues: effects of nicotine deprivation. Psychopharmacology, 173, 116-23.
19. Franken, I.H.A. (2003). Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 27(4), 563-79.
20. Franken, I.H.A., Hendriks, V.M., Stam, C.J., Van den Brink, W. (2004). A role for dopamine in the processing of drug cues in heroin dependent patients. European Neuropsychopharmacology, 14(6), 503-8.
21. Freeman, T.P., Morgan, C.J., Beesley, T., Curran, H.V. (2012a). Drug cue induced overshadowing: selective disruption of natural reward processing by cigarette cues amongst abstinent but not satiated smokers. Psychological Medicine, 42(1), 161-71.
22. Freeman, T.P., Morgan, C.J.A., Brandner, B., Almahdi, B., Curran, H.V. (2012b). Dopaminergic involvement in effort-based but not impulsive reward processing in smokers. Drug and Alcohol Dependence, 130(1), 103-9.
23. Garland, E.L., Franken, I.H.A., Howard, M.O. (2012). Cue-elicited heart rate variability and attentional bias predict alcohol relapse following treatment. Psychopharmacology, 222, 17-26.
24. Goldstein, R., Woicik, P., Lukasik, T., Maloney, T., Volkow, N. (2007). Drug fluency: a potential marker for cocaine use disorders. Drug and Alcohol Dependence, 89(1), 97-101.
25. Goldstein, R.Z., Tomasi, D., Alia-Klein, N., et al. (2009). Dopaminergic response to drug words in cocaine addiction. The Journal of Neuroscience, 29(18), 6001-6.
26. Goldstein, R.Z., Volkow, N.D. (2011). Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nature Reviews Neuroscience, 12(11), 652-69.
27. Grace, A. (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience, 41(1), 1-24.
28. Hamidovic, A., Kang, U.J., de Wit, H. (2008). Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. Journal of Clinical Psychopharmacology, 28(1), 45-51.
29. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerstrom, K.-O. (1991). The Fagerström test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction, 86(9), 1119-27.
30. Heishman, S.J., Singleton, E.G., Pickworth, W.B. (2008). Reliability and validity of a short form of the tobacco craving questionnaire. Nicotine & Tobacco Research, 10(4), 643-51.
31. Hitsman, B., Hogarth, L., Tseng, L.-J., et al. (2012). Dissociable effect of acute varenicline on tonic versus cue-provoked craving in non-treatment-motivated heavy smokers. Drug and Alcohol Dependence, 130, 135-51.
32. Hitsman, B., MacKillop, J., Lingford-Hughes, A., et al. (2008). Effects of acute tyrosine/ phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers. Psychopharmacology, 196(4), 611-21.
33. Janes, A.C., Pizzagalli, D.A., Richardt, S. (2010). Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biological Psychiatry, 67(8), 722.
34. Jarvik, M.E., Caskey, N.H., Wirshing, W.C., Madsen, D.C., Iwamoto-Schaap, P.N., Elins, J.L. (2000). Bromocriptine reduces cigarette smoking. Addiction, 95(8), 1173-83.
35. Kotz, D., Brown, J., West, R. (2012). Predictive validity of the motivation to stop scale (MTSS): a single-item measure of motivation to stop smoking. Drug and Alcohol Dependence, 128, 15-9.
36. Lubman, D.I., Yucel, M., Kettle, J.W.L., et al. (2009). Responsiveness to drug cues and natural rewards in opiate addiction: associations with later heroin use. Archives of General Psychiatry, 66(2), 205.
37. Luijten, M., Veltman, D.J., den Brink, W., et al. (2011). Neurobiological substrate of smoking-related attentional bias. Neuroimage, 54(3), 2374-81.
38. Luijten, M., Veltman, D.J., Hester, R., Smits, M., Pepplinkhuizen, L., Franken, I.H.A. (2012). Brain activation associated with attentional bias in smokers is modulated by a dopamine antagonist. Neuropsychopharmacology, 37(13), 2772-9.
39. Maj, J., Rogoz, Z., Skuza, G., Kolodziejczyk, K. (1997). The behavioural effects of pramipexole, a novel dopamine receptor agonist. European Journal of Pharmacology, 324(1), 31.
40. Marissen, M.A.E., Franken, I.H.A., Waters, A.J., Blanken, P., Van Den Brink, W., Hendriks, V.M. (2006). Attentional bias predicts heroin relapse following treatment. Addiction, 101(9), 1306-12.
41. Mehta, M.A., Manes, F.F., Magnolfi, G., Sahakian, B.J., Robbins, T.W. (2004). Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology, 176(3-4), 331-42.
42. Mogg, K., Bradley, B.P., Field, M., De Houwer, J. (2003). Eye movements to smokingrelated pictures in smokers: relationship between attentional biases and implicit and explicit measures of stimulus valence. Addiction, 98(6), 825-36.
43. Morgan, C., Rees, H., Curran, H. (2008). Attentional bias to incentive stimuli in frequent ketamine users. Psychological Medicine, 38(9), 1331-40.
44. Morgan, C.J.A., Freeman, T.P., Schafer, G.L., Curran, H.V. (2010). Cannabidiol attenuates the appetitive effects of [Delta]9-tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology, 35(9), 1879-85.
45. Munafò , M.R., Mannie, Z.N., Cowen, P.J., Harmer, C.J., McTavish, S.B. (2007). Effects of acute tyrosine depletion on subjective craving and selective processing of smokingrelated cues in abstinent cigarette smokers. Journal of Psychopharmacology, 21(8), 805-14.
46. Murphy, M.F., Hey, K., Johnstone, E., Munafò , M., Walton, R., Willis, B., Harrison, P.J. (2002). Bromocriptine use is associated with decreased smoking rates. Addiction Biology, 7(3), 325-8.
47. Myrtek, M., Foerster, F. (1986). The law of initial value: a rare exception. Biological Psychology, 22(3), 227-39.
48. Parkes, J.D. (1986). Domperidone and Parkinson's disease. Clinical Neuropharmacology, 9(6), 517-32.
49. Petry, N.M. (2000). A comprehensive guide to the application of contingency management procedures in clinical settings. Drug and Alcohol Dependence, 58(1), 9-25.
50. Phillips, P.E.M., Stuber, G.D., Heien, M., Wightman, R.M., Carelli, R.M. (2003). Subsecond dopamine release promotes cocaine seeking. Nature, 422(6932), 614-8.
51. Pizzagalli, D.A., Evins, A.E., Schetter, E.C., et al. (2008). Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness. Psychopharmacology, 196(2), 221-32.
52. Powell, J., Dawkins, L., West, R., Powell, J., Pickering, A. (2010). Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology, 212(4), 537-49.
53. Robinson, T.E., Berridge, K.C. (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research Reviews, 18(3), 247-91.
54. Schoenmakers, T.M., de Bruin, M., Lux, I.F.M., Goertz, A.G., Van Kerkhof, D.H.A.T., Wiers, R.W. (2010). Clinical effectiveness of attentional bias modification training in abstinent alcoholic patients. Drug and Alcohol Dependence, 109(1), 30-6.
55. Schultz, W., Dayan, P., Montague, P.R. (1997). A neural substrate of prediction and reward. Science, 275(5306), 1593-9.
56. Teicher, M.H., Polcari, A., Anderson, C.M., Andersen, S.L., Lowen, S.B., Navalta, C.P. (2003). Rate dependency revisited: understanding the effects of methylphenidate in children with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 13(1), 41-51.
57. Versace, F., Lam, C.Y., Engelmann, J.M., Robinson, J.D., Minnix, J.A., Brown, V.L., Cinciripini, P.M. (2011). Beyond cue reactivity: blunted brain responses to pleasant stimuli predict long-term smoking abstinence. Addiction Biology, 17(6), 991-1000.
58. Vollstädt-Klein, S., Loeber, S., Richter, A., et al. (2011). Validating incentive salience with functional magnetic resonance imaging: association between mesolimbic cue reactivity and attentional bias in alcohol-dependent patients. Addiction Biology, 17(4), 807-16.
59. Waters, A.J., Shiffman, S., Sayette, M.A., Paty, J.A., Gwaltney, C.J., Balabanis, M.H. (2003). Attentional bias predicts outcome in smoking cessation. Health Psychology, 22(4), 378.
60. West, R., Hajek, P. (2004). Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology, 177(1), 195-9.
61. Wright, C.E., Sisson, T., Ichhpurani, A., Peters, G.R. (1997). Steady-state pharmacokinetic properties of pramipexole in healthy volunteers. The Journal of Clinical Pharmacology, 37(6), 520-5.